US FDA has greenlighted Senseonics’ Eversense 365 continuous glucose monitor. The fully implantable device is replaced once a year, lasting 185 days longer than the Eversense E3 sensor and outstripping competing CGMs, which last only for 10-14 days.
Senseonics Holdings and Ascensia Diabetes Care are targeting the 2024 fourth quarter for launch of the world’s first 365-day continuous glucose monitoring system, Eversense 365.
Senseonics has been working to extend the wear life of its fully implantable Eversense glucose sensors since receiving PMA approval...
Exact Sciences has entered into an exclusive licensing agreement with Freenome, stipulating clinical benchmarks and a first-line rating in the USPSTF guidelines. Medtech Insight interviewed screening CMO Paul Limburg about CRC screening and Exact’s strategy on liquid biopsy.
An interactive look at medtech and diagnostics deals made during July 2025. Data courtesy of Biomedtracker.
The FDA's Device Clinical Trial Snapshot Pilot, aimed at increasing trial transparency and diversity, has been canceled following President Trump’s anti-DEI executive order. Critics warn this may hinder trial transparency, impacting public health and demographic data accessibility.
Fresh off an IPO, spinal implant maker Carlsmed is preparing to launch a new cervical fusion application for its aprevo tech. Medtech Insight has two perspectives on these recent moves: CEO Mike Cordonnier and the doctor who performed the first spinal fusion using the technology.
2026 reimbursement calculations for the list of hybrid DRGs – a mechanism to incentivize day cases over inpatient surgery – will be issued in few weeks’ time. The medtech industry has made its demands known.
An interactive look at medtech and diagnostics deals made during July 2025. Data courtesy of Biomedtracker.
The FDA's Device Clinical Trial Snapshot Pilot, aimed at increasing trial transparency and diversity, has been canceled following President Trump’s anti-DEI executive order. Critics warn this may hinder trial transparency, impacting public health and demographic data accessibility.
